Feedback / Questions
ATLX-1088 - Alchemab Therap
https://www.prnewswire.com/news-releases/alchemab-therapeutics-unveils-alzheimers-candidate-atlx-1088-targeting-cd33-at-the-antibody-industrial-symposium-301857675.html
Jun 22, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev